NIH Licenses COVID-19 Research Tools
Recently at the second Global COVID-19 Summit, President Biden announced that the Biden-Harris administration, through the U.S. National Institutes of Health, has licensed 11 COVID-19 research tools and early-stage vaccine and diagnostic candidates to the Medicines Patent Pool through the World Health Organization’s COVID-19 Technology Access Pool.




